Lise Gravelle

Lise Gravelle has over 30 years of experience in the pharmaceutical industry. Lise started their career at Merck Frosst Canada in 1991, where they worked as a Senior Research Chemist. Their responsibilities included authoring CMC sections for regulatory filings, preparing responses to regulatory agencies, and evaluating changes to manufacturing and testing processes. Lise worked at Merck Frosst Canada until 2008.

In 2009, Lise joined EZEM Canada as an Associate Manager QC. Lise then moved on to Bellus Health in 2010, where they held the position of Manager Drug Development. At Bellus Health, Lise managed outsourced CMC activities for drug substance and drug product, as well as prepared documents for regulatory filings.

In 2011, Lise joined InSymbiosis as a Senior Project Director. Their role involved managing early phase drug development programs, with a focus on CMC activities. Lise was responsible for preparing documentation for regulatory filings and conducting audits of vendors conducting GMP and GLP activities.

Since 2014, Lise has been working at Galecto, Inc., initially as the Director of CMC and currently as the VP CMC. Their responsibilities at Galecto include overseeing CMC activities and leading the team in regulatory submissions.

Throughout their career, Lise has demonstrated a strong expertise in CMC activities, regulatory filings, and managing drug development programs.

Lise Gravelle obtained a Bachelor of Science degree in Biochemistry from Concordia University, spanning from 1984 to 1987.